Regulation of multidrug resistance by microRNAs in anti-cancer therapy
Multidrug resistance (MDR) remains a major clinical obstacle to successful cancer treatment. Although diverse mechanisms of MDR have been well elucidated, such as dysregulation of drugs transporters, defects of apoptosis and autophagy machinery, alterations of drug metabolism and drug targets, disru...
Saved in:
Main Authors: | Xin An (Author), Cesar Sarmiento (Author), Tao Tan (Author), Hua Zhu (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2017-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
MicroRNAs as the critical regulators of Cisplatin resistance in ovarian cancer cells
by: Meysam Moghbeli
Published: (2021) -
MicroRNAs as Molecular Targets for Cancer Therapy: On the Modulation of MicroRNA Expression
by: Pedro M. Costa, et al.
Published: (2013) -
Regulation of Eicosanoid Pathways by MicroRNAs
by: Meike J. Saul, et al.
Published: (2019) -
MicroRNAs as Novel Regulators of Neuroinflammation
by: Dominika Justyna Ksiazek-Winiarek, et al.
Published: (2013) -
Cancer Cachexia and MicroRNAs
by: Rodolfo Gonzalez Camargo, et al.
Published: (2015)